Welcome to CSNpharm! For Research Use Only!
NMDAR
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN21328 | UK-240455 | 178908-09-3 | UK-240455 is a potent and selective N-methyl D-aspartate NMDA glycine site antagonist |
| CSN24287 | Traxoprodil mesylate | 189894-57-3 | Traxoprodil a selective antagonist of the NR2B subunit of the NMDA receptor. |
| CSN12978 | Traxoprodil | 134234-12-1 | Traxoprodil a selective antagonist of the NR2B subunit of the NMDA receptor |
| CSN21414 | Transcrocetin Meglumine Salt | N/A | Transcrocetin meglumine salt extracted from saffron Crocus sativus L acts as an NMDA receptor antagonist with high affinity |
| CSN11907 | SDZ 220-581 | 174575-17-8 | SDZ 220-581 is a potent competitive antagonist at the NMDA glutamate receptor subtype pKi 77 |
| CSN18033 | SDZ 220-581 HCl | 179411-93-9 | SDZ 220-581 HCl is a potent, competitive antagonist at the NMDA glutamate receptor subtype (pKi= 7.7). |
| CSN18034 | SDZ 220-581 Ammonium | 179411-94-0 | SDZ 220-581 ammonium is a potent competitive antagonist at the NMDA glutamate receptor subtype pKi 77 |
| CSN15699 | Sarcosine | 107-97-1 | Sarcosine is an NMDAR co-agonist at the glycine binding site. It is an intermediate and byproduct in glycine synthesis and degradation. |
| CSN17681 | Ro 25-6981 Maleate | 1312991-76-6 | Ro 25-6981 maleate is a potent and selective activity-dependent blocker of NMDA receptors containing the NR2B subunit |
| CSN17353 | Ro 25-6981 | 169274-78-6 | Ro 25-6981 is a potent and selective activity-dependent blocker of NMDA receptors containing the NR2B subunit |
| CSN17520 | Rapastinel | 117928-94-6 | Rapastinel is a putative NMDAR functional glycine-site partial agonist |
| CSN23784 | Radiprodil | 496054-87-6 | Radiprodil is a selective antagonist of NMDA NR2B that used in treatment of neuropathic pain. |
| CSN23523 | Quinolinic acid | 89-00-9 | Quinolinic acid is both a selective agonist at NMDA receptors and also a precursor for the formation of NAD |
| CSN16857 | QNZ46 | 1237744-13-6 | QNZ46 is a noncompetitive and voltage-independent GluN2CGluN2D-selective NMDA antagonist with IC50 values of 3 6 229 M for GluN2D GluN2C GluN2A respectively |
| CSN11780 | Procyclidine HCl | 1508-76-5 | Procyclidine HCl is an potent anti-cholinergic agent, and is also known to have NMDA antagonist properties. |
| CSN17346 | PEAQX | 459836-30-7 | PEAQX is a potent and orally active NMDA antagonist with a 15-fold preference for human NMDA receptors with the 1A2A IC50270 nM rather than 1A2B29600 nM |
| CSN19272 | PEAQX Tetrasodium Hydrate | N/A | PEAQX is a potent and orally active NMDA antagonist with a 15-fold preference for human NMDA receptors with the 1A2A IC50270 nM rather than 1A2B29600 nM |
| CSN11619 | Orphenadrine HCl | 341-69-5 | Orphenadrine HCl is an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist with Ki of 6.0 ±0.7 μM. |
| CSN11618 | Orphenadrine Citrate | 4682-36-4 | Orphenadrine Citrate is both an uncompetitive NMDA receptor antagonist IC50 value of 162 M and a mAChR antagonist with IC50 value of 037 M |
| CSN24186 | NMDAR antagonist 1 | 2220162-06-9 | NMDAR antagonist 1 is a NR2B-selective NMDAR antagonist. |
| CSN17347 | NMDA-IN-1 | 700878-19-9 | NMDA-IN-1 is a potent and NR2B-selective NMDA antagonist with Ki of 085 nM Its NR2B Ca2 influx IC50 is 97 nM without activities on NR2A NR2C NR2D hERG-channel and 1-adrenergic receptor |
| CSN13790 | NMDA | 6384-92-5 | NMDA is an amino acid derived specific agonist at the NMDA receptor |
| CSN11379 | Mephenesin | 59-47-2 | Mephenesin is a centrally acting muscle relaxant which may work as an NMDA receptor antagonist. |
| CSN11501 | Memantine | 19982-08-2 | Memantine is the first in a class of Alzheimers disease medications acting on the glutamatergic system by blocking NMDA receptors |
| CSN13695 | MDL-29951 | 130798-51-5 | MDL-29951 is a glycine antagonist of NMDA receptor activation Ki014 mM 3Hglycine binding in vitro and in vivo |
| CSN13916 | MDL 105519 | 161230-88-2 | MDL 105519 is a potent and selective inhibitor of 3Hglycine binding to the NMDA receptor with Kd of 389 nM |
| CSN20030 | Lanicemine | 153322-05-5 | Lanicemine is a low-trapping NMDA receptor antagonist Lanicemine is used the management of severe and treatment-resistant depression Lanicemine was originally developed as a neuroprotective agent but was redeveloped as an antidepressant |
| CSN17128 | L-701,324 | 142326-59-8 | L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor |
| CSN21303 | Kynurenic Acid Sodium | 2439-02-3 | Kynurenic acid, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, 7 nicotinic acetylcholine receptor. Kynurenic acid is also a selective ligand of the GPR35 receptor. |
| CSN11186 | Ifenprodil Tartrate | 23210-58-4 | Ifenprodil Tartrate is a high affinity and atypical noncompetitive NMDA receptor antagonist with IC50 of 03 M |
| CSN21125 | Ibotenic Acid | 2552-55-8 | Ibotenic acid has agonist activity at both the N-methyl-D-aspartate NMDA and trans-ACPD or metabolotropic quisqualate Qm receptor sites |
| CSN22199 | GNE 5729 | 2026635-66-3 | GNE 5729 is a brain permeable positive allosteric modulator of NMDAR with an EC50 of 37 nM for GluN2A 47 and 95 M for GluN2C and GluN2D respectively |
| CSN22417 | GNE 0723 | 1883518-31-7 | GNE 0723 is a brain permeable positive allosteric modulator of NMDAR with an EC50 of 21 nM for GluN2A 74 and 62 M for GluN2C and GluN2D respectively |
| CSN10988 | Felbamate | 25451-15-4 | Felbamate is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate NMDA |
| CSN17519 | Felbamate Hydrate | 1177501-39-1 | Felbamate is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate NMDA |
| CSN10256 | Eliprodil | 119431-25-3 | Eliprodil can antogonize GluN2B-selective NMDA in a non-competitive manner with IC50 value of 1 M It is also a 1 ligand with Ki value of 0013 M |
| CSN21590 | D-AP5 | 79055-68-8 | D-AP5 is an antagonist of NMDA receptor (N-methyl-D-aspartate receptor). |
| CSN18296 | CIQ | 486427-17-2 | CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit |
| CSN19842 | CGP 37849 | 127910-31-0 | CGP 37849 is a potent selective and competitive NMDA receptor antagonist Ki 35 nM |
| CSN10502 | Budipine | 57982-78-2 | Budipine is an uncompetitive NMDAR antagonist used as an antiparkinson agent |
| CSN22349 | Apimostinel | 1421866-48-9 | Apimostinel is an oral NMDA receptor partial agonist. |
| CSN22086 | 7-Chlorokynurenic Acid Sodium Salt | 1263094-00-3 | 7-Chlorokynurenic acid sodium salt is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex and also a potent inhibitor of the reuptake of glutamate into synaptic vesicles with Ki of 0.59 μM. |
| CSN24923 | 6-Methoxy-2-naphthoic acid | 2471-70-7 | 6-Methoxy-2-naphthoic acid is an modulator of NMDAR. |
| CSN17580 | (-)-MK 801 Maleate | 121917-57-5 | --MK 801 maleate is the enantiomer of -MK-801 which is a highly potent and selective non-competitive NMDA glutamate receptor antagonist |
| CSN23429 | L-Glutamic Acid | 56-86-0 | (S)-Glutamic acid acts as an excitatory neurotransmitter in the central nervous system. |
| CSN13883 | (+)-MK 801 Maleate | 77086-22-7 | ()-MK 801 Maleate is a highly potent, selective and non-competitive NMDA receptor antagonist with Ki of 30.5 nM. |
| CSN25441 | (-)-Aspartic acid | 1783-96-6 | |
| CSN25440 | ACBC | 22264-50-2 |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
